According to the well-known Swedish AMORIS trial, ALB levels were found to be favorably associated with GS 4 + 3 prostate cancer and negatively associated with high-risk or metastatic prostate cancer 14 years before diagnosis (27). This evidence concerns the gene ALB and Familial prostate cancer.